MTN 016 (EMBRACE)
Status:Ongoing
Phase:Open Label
Principal Investigator(s):Richard Beigi
Objective:To learn whether using a vaginal microbicide or antiretroviral (ARV) tablets affects a woman’s pregnancy outcome and her baby's health and development.
Prevention Option(s):Microbicides, PrEP
Study Design:
Results: Pregnancy and Infant Outcomes Among Women Using the Dapivirine Vaginal Ring in Early Pregnancy
Official Code:
NCT01209754
Trial Sponsors:
CONRAD, MTN, NIAID, NICHD
Start Date
End Date
October 31, 2009
November 18, 2020
Enrollment:873
Age range:
1 Months ↔
any
Population:Pregnant and Lactating Populations